van Der Looij M - Search Results

1

Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.

van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E. van Der Looij M, et al. Hum Mutat. 2000 May;15(5):480-1. doi: 10.1002/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G. Hum Mutat. 2000. PMID: 10790213

2

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E. Van Der Looij M, et al. Int J Cancer. 2000 Jun 1;86(5):737-40. doi: 10.1002/(sici)1097-0215(20000601)86:5<737::aid-ijc21>3.0.co;2-1. Int J Cancer. 2000. PMID: 10797299

3

Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, Ponder BA, Olah E. Ramus SJ, et al. Among authors: van der looij m. Am J Hum Genet. 1997 May;60(5):1242-6. Am J Hum Genet. 1997. PMID: 9150174 Free PMC article. No abstract available.

4

A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1.

van der Looij M, Cleton-Jansen AM, van Eijk R, Morreau H, van Vliet M, Kuipers-Dijkshoorn N, Oláh E, Cornelisse CJ, Devilee P. van der Looij M, et al. Genes Chromosomes Cancer. 2000 Mar;27(3):295-302. doi: 10.1002/(sici)1098-2264(200003)27:3<295::aid-gcc10>3.0.co;2-f. Genes Chromosomes Cancer. 2000. PMID: 10679919

5

Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.

van der Looij M, Papp J, Sztán M, Pulay T, Elfadil I, Besznyak I, Tóth J, Devilee P, Oláh E. van der Looij M, et al. Int J Oncol. 2001 Apr;18(4):775-80. Int J Oncol. 2001. PMID: 11251173

6

Allele loss of tumour suppressor genes on chromosome 17 in human testicular germ cell tumours.

Vanderlooij M, Eid H, Bak M, Bodrogi I, Olah E. Vanderlooij M, et al. Int J Oncol. 1996 Nov;9(5):1087-90. doi: 10.3892/ijo.9.5.1087. Int J Oncol. 1996. PMID: 21541616

7

Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer?

Eid H, Van der Looij M, Institoris E, Géczi L, Bodrogi I, Oláh E, Bak M. Eid H, et al. Among authors: van der looij m. Anticancer Res. 1997 Jul-Aug;17(4A):2663-9. Anticancer Res. 1997. PMID: 9252698

8

Vitamin E protects against iron-hexachlorobenzene induced porphyria and formation of 8-hydroxydeoxyguanosine in the liver of C57BL/10ScSn mice.

Horváth ME, Faux SP, Smith AG, Blázovics A, van der Looij M, Fehér J, Cheeseman KH. Horváth ME, et al. Among authors: van der looij m. Toxicol Lett. 2001 May 31;122(1):97-102. doi: 10.1016/s0378-4274(01)00350-2. Toxicol Lett. 2001. PMID: 11397561

9

Effect of silibinin and vitamin E on restoration of cellular immune response after partial hepatectomy.

Horváth ME, González-Cabello R, Blázovics A, van der Looij M, Barta I, Müzes G, Gergely P, Fehér J. Horváth ME, et al. Among authors: van der looij m. J Ethnopharmacol. 2001 Oct;77(2-3):227-32. doi: 10.1016/s0378-8741(01)00298-7. J Ethnopharmacol. 2001. PMID: 11535368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters